In 2023, Hua Medicine completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Hua Medicine has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hua Medicine’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Hua Medicine amounted to 435.747 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Hua Medicine increased by 32.24%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b
In 2023, the total Scope 1 emissions of Hua Medicine were 19.201 metric tons of CO₂ equivalent (tCO₂e). a
Since 2021, Hua Medicine's Scope 1 emissions have increased by 26.41%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Hua Medicine's Scope 1 emissions increased by 11.83%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a b
In 2023, Hua Medicine reported Scope 2 greenhouse gas (GHG) emissions of 416.546 tCO₂e without specifying the calculation method. a
Since 2021, Hua Medicine's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Hua Medicine 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2022), Hua Medicine's Scope 2 emissions (Unspecified Calculation Method) rose by 33.37% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a b
In 2023, Hua Medicine reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Hua Medicine reported Scope 1 greenhouse gas (GHG) emissions of 19.201 tCO₂e and total revenues of USD 12 millions. This translates into an emissions intensity of 1.63 tCO₂e per millions USD. a
In 2023, Hua Medicine reported a Scope 1 emissions intensity of 1.63 tCO₂e per millions USD. Compared to the peer group median of 27.66 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Hua Medicine ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Hua Medicine among the top performers, with one of the lowest emissions intensities relative to peers. a